NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $19.5M of Intellia Therapeutics, Inc.
Sold$19,520,418
$160.83Price
121,372Shares
−13%Stake
What NTLA did after the filing
- The stock from Thu, Sep 2 open, $164.31
- −20.6%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Oct 15 close.
Traded Mon, Aug 30. Filed Wed, Sep 1, 8:21 PM ET, after the close. Returns use the Sep 2 open and the Oct 15 close. Not investment advice.